Summary

The global Paliperidone Palmitate Therapeutic Injection market size is predicted to grow from US$ 4246 million in 2025 to US$ 6207 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Paliperidone palmitate therapeutic injection is a long-acting sustained-release antipsychotic drug, the main ingredient of which is paliperidone palmitate. It is administered by intramuscular injection and can gradually release the drug in the body to achieve a sustained and stable therapeutic effect. The injection is mainly used to treat schizophrenia and schizoaffective disorder, helping to improve patients' symptoms, reduce relapse rates, and improve medication compliance. It is particularly suitable for patients who need long-term maintenance treatment.
United States market for Paliperidone Palmitate Therapeutic Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Paliperidone Palmitate Therapeutic Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Paliperidone Palmitate Therapeutic Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Paliperidone Palmitate Therapeutic Injection players cover Janssen Pharmaceuticals, Teva Pharmaceutical, Viatris, Sun Pharmaceutical, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Paliperidone Palmitate Therapeutic Injection Industry Forecast” looks at past sales and reviews total world Paliperidone Palmitate Therapeutic Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Paliperidone Palmitate Therapeutic Injection sales for 2025 through 2031. With Paliperidone Palmitate Therapeutic Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paliperidone Palmitate Therapeutic Injection industry.
This Insight Report provides a comprehensive analysis of the global Paliperidone Palmitate Therapeutic Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paliperidone Palmitate Therapeutic Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paliperidone Palmitate Therapeutic Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paliperidone Palmitate Therapeutic Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paliperidone Palmitate Therapeutic Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Paliperidone Palmitate Therapeutic Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monthly Dosage Form
Quarterly Dosage Form
Segmentation by Application:
General Hospital
Specialized Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Janssen Pharmaceuticals
Teva Pharmaceutical
Viatris
Sun Pharmaceutical
Cipla
Hikma Pharmaceuticals
Qilu Pharmaceutical
Hansoh Pharmaceuticak Group
Luye Pharma Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Paliperidone Palmitate Therapeutic Injection market?
What factors are driving Paliperidone Palmitate Therapeutic Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paliperidone Palmitate Therapeutic Injection market opportunities vary by end market size?
How does Paliperidone Palmitate Therapeutic Injection break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paliperidone Palmitate Therapeutic Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Paliperidone Palmitate Therapeutic Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Paliperidone Palmitate Therapeutic Injection by Country/Region, 2020, 2024 & 2031
2.2 Paliperidone Palmitate Therapeutic Injection Segment by Type
2.2.1 Monthly Dosage Form
2.2.2 Quarterly Dosage Form
2.3 Paliperidone Palmitate Therapeutic Injection Sales by Type
2.3.1 Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Paliperidone Palmitate Therapeutic Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Paliperidone Palmitate Therapeutic Injection Sale Price by Type (2020-2025)
2.4 Paliperidone Palmitate Therapeutic Injection Segment by Application
2.4.1 General Hospital
2.4.2 Specialized Hospital
2.4.3 Others
2.5 Paliperidone Palmitate Therapeutic Injection Sales by Application
2.5.1 Global Paliperidone Palmitate Therapeutic Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Paliperidone Palmitate Therapeutic Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Paliperidone Palmitate Therapeutic Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Paliperidone Palmitate Therapeutic Injection Breakdown Data by Company
3.1.1 Global Paliperidone Palmitate Therapeutic Injection Annual Sales by Company (2020-2025)
3.1.2 Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Company (2020-2025)
3.2 Global Paliperidone Palmitate Therapeutic Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Paliperidone Palmitate Therapeutic Injection Revenue by Company (2020-2025)
3.2.2 Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Company (2020-2025)
3.3 Global Paliperidone Palmitate Therapeutic Injection Sale Price by Company
3.4 Key Manufacturers Paliperidone Palmitate Therapeutic Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paliperidone Palmitate Therapeutic Injection Product Location Distribution
3.4.2 Players Paliperidone Palmitate Therapeutic Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Paliperidone Palmitate Therapeutic Injection by Geographic Region
4.1 World Historic Paliperidone Palmitate Therapeutic Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Paliperidone Palmitate Therapeutic Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Paliperidone Palmitate Therapeutic Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Paliperidone Palmitate Therapeutic Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Paliperidone Palmitate Therapeutic Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Paliperidone Palmitate Therapeutic Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Paliperidone Palmitate Therapeutic Injection Sales Growth
4.4 APAC Paliperidone Palmitate Therapeutic Injection Sales Growth
4.5 Europe Paliperidone Palmitate Therapeutic Injection Sales Growth
4.6 Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales Growth
5 Americas
5.1 Americas Paliperidone Palmitate Therapeutic Injection Sales by Country
5.1.1 Americas Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025)
5.1.2 Americas Paliperidone Palmitate Therapeutic Injection Revenue by Country (2020-2025)
5.2 Americas Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025)
5.3 Americas Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paliperidone Palmitate Therapeutic Injection Sales by Region
6.1.1 APAC Paliperidone Palmitate Therapeutic Injection Sales by Region (2020-2025)
6.1.2 APAC Paliperidone Palmitate Therapeutic Injection Revenue by Region (2020-2025)
6.2 APAC Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025)
6.3 APAC Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Paliperidone Palmitate Therapeutic Injection by Country
7.1.1 Europe Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025)
7.1.2 Europe Paliperidone Palmitate Therapeutic Injection Revenue by Country (2020-2025)
7.2 Europe Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025)
7.3 Europe Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paliperidone Palmitate Therapeutic Injection by Country
8.1.1 Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Paliperidone Palmitate Therapeutic Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paliperidone Palmitate Therapeutic Injection
10.3 Manufacturing Process Analysis of Paliperidone Palmitate Therapeutic Injection
10.4 Industry Chain Structure of Paliperidone Palmitate Therapeutic Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paliperidone Palmitate Therapeutic Injection Distributors
11.3 Paliperidone Palmitate Therapeutic Injection Customer
12 World Forecast Review for Paliperidone Palmitate Therapeutic Injection by Geographic Region
12.1 Global Paliperidone Palmitate Therapeutic Injection Market Size Forecast by Region
12.1.1 Global Paliperidone Palmitate Therapeutic Injection Forecast by Region (2026-2031)
12.1.2 Global Paliperidone Palmitate Therapeutic Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Paliperidone Palmitate Therapeutic Injection Forecast by Type (2026-2031)
12.7 Global Paliperidone Palmitate Therapeutic Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Janssen Pharmaceuticals
13.1.1 Janssen Pharmaceuticals Company Information
13.1.2 Janssen Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.1.3 Janssen Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Janssen Pharmaceuticals Main Business Overview
13.1.5 Janssen Pharmaceuticals Latest Developments
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Information
13.2.2 Teva Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Main Business Overview
13.2.5 Teva Pharmaceutical Latest Developments
13.3 Viatris
13.3.1 Viatris Company Information
13.3.2 Viatris Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.3.3 Viatris Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Viatris Main Business Overview
13.3.5 Viatris Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.5.3 Cipla Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Hikma Pharmaceuticals
13.6.1 Hikma Pharmaceuticals Company Information
13.6.2 Hikma Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.6.3 Hikma Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hikma Pharmaceuticals Main Business Overview
13.6.5 Hikma Pharmaceuticals Latest Developments
13.7 Qilu Pharmaceutical
13.7.1 Qilu Pharmaceutical Company Information
13.7.2 Qilu Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.7.3 Qilu Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Qilu Pharmaceutical Main Business Overview
13.7.5 Qilu Pharmaceutical Latest Developments
13.8 Hansoh Pharmaceuticak Group
13.8.1 Hansoh Pharmaceuticak Group Company Information
13.8.2 Hansoh Pharmaceuticak Group Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.8.3 Hansoh Pharmaceuticak Group Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hansoh Pharmaceuticak Group Main Business Overview
13.8.5 Hansoh Pharmaceuticak Group Latest Developments
13.9 Luye Pharma Group
13.9.1 Luye Pharma Group Company Information
13.9.2 Luye Pharma Group Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
13.9.3 Luye Pharma Group Paliperidone Palmitate Therapeutic Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Luye Pharma Group Main Business Overview
13.9.5 Luye Pharma Group Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Paliperidone Palmitate Therapeutic Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Paliperidone Palmitate Therapeutic Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monthly Dosage Form
Table 4. Major Players of Quarterly Dosage Form
Table 5. Global Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025) & (K Dose)
Table 6. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
Table 7. Global Paliperidone Palmitate Therapeutic Injection Revenue by Type (2020-2025) & ($ million)
Table 8. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Type (2020-2025)
Table 9. Global Paliperidone Palmitate Therapeutic Injection Sale Price by Type (2020-2025) & (US$/Dose)
Table 10. Global Paliperidone Palmitate Therapeutic Injection Sale by Application (2020-2025) & (K Dose)
Table 11. Global Paliperidone Palmitate Therapeutic Injection Sale Market Share by Application (2020-2025)
Table 12. Global Paliperidone Palmitate Therapeutic Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Paliperidone Palmitate Therapeutic Injection Sale Price by Application (2020-2025) & (US$/Dose)
Table 15. Global Paliperidone Palmitate Therapeutic Injection Sales by Company (2020-2025) & (K Dose)
Table 16. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Company (2020-2025)
Table 17. Global Paliperidone Palmitate Therapeutic Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Paliperidone Palmitate Therapeutic Injection Sale Price by Company (2020-2025) & (US$/Dose)
Table 20. Key Manufacturers Paliperidone Palmitate Therapeutic Injection Producing Area Distribution and Sales Area
Table 21. Players Paliperidone Palmitate Therapeutic Injection Products Offered
Table 22. Paliperidone Palmitate Therapeutic Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Paliperidone Palmitate Therapeutic Injection Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Paliperidone Palmitate Therapeutic Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Paliperidone Palmitate Therapeutic Injection Sales by Country/Region (2020-2025) & (K Dose)
Table 30. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Paliperidone Palmitate Therapeutic Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025) & (K Dose)
Table 34. Americas Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Paliperidone Palmitate Therapeutic Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025) & (K Dose)
Table 37. Americas Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025) & (K Dose)
Table 38. APAC Paliperidone Palmitate Therapeutic Injection Sales by Region (2020-2025) & (K Dose)
Table 39. APAC Paliperidone Palmitate Therapeutic Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Paliperidone Palmitate Therapeutic Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025) & (K Dose)
Table 42. APAC Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025) & (K Dose)
Table 43. Europe Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025) & (K Dose)
Table 44. Europe Paliperidone Palmitate Therapeutic Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025) & (K Dose)
Table 46. Europe Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Type (2020-2025) & (K Dose)
Table 50. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Paliperidone Palmitate Therapeutic Injection
Table 52. Key Market Challenges & Risks of Paliperidone Palmitate Therapeutic Injection
Table 53. Key Industry Trends of Paliperidone Palmitate Therapeutic Injection
Table 54. Paliperidone Palmitate Therapeutic Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Paliperidone Palmitate Therapeutic Injection Distributors List
Table 57. Paliperidone Palmitate Therapeutic Injection Customer List
Table 58. Global Paliperidone Palmitate Therapeutic Injection Sales Forecast by Region (2026-2031) & (K Dose)
Table 59. Global Paliperidone Palmitate Therapeutic Injection Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Paliperidone Palmitate Therapeutic Injection Sales Forecast by Country (2026-2031) & (K Dose)
Table 61. Americas Paliperidone Palmitate Therapeutic Injection Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Paliperidone Palmitate Therapeutic Injection Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. APAC Paliperidone Palmitate Therapeutic Injection Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Paliperidone Palmitate Therapeutic Injection Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Europe Paliperidone Palmitate Therapeutic Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales Forecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Paliperidone Palmitate Therapeutic Injection Sales Forecast by Type (2026-2031) & (K Dose)
Table 69. Global Paliperidone Palmitate Therapeutic Injection Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Paliperidone Palmitate Therapeutic Injection Sales Forecast by Application (2026-2031) & (K Dose)
Table 71. Global Paliperidone Palmitate Therapeutic Injection Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Janssen Pharmaceuticals Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Janssen Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 74. Janssen Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 75. Janssen Pharmaceuticals Main Business
Table 76. Janssen Pharmaceuticals Latest Developments
Table 77. Teva Pharmaceutical Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 79. Teva Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 80. Teva Pharmaceutical Main Business
Table 81. Teva Pharmaceutical Latest Developments
Table 82. Viatris Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Viatris Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 84. Viatris Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 85. Viatris Main Business
Table 86. Viatris Latest Developments
Table 87. Sun Pharmaceutical Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Sun Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 89. Sun Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 90. Sun Pharmaceutical Main Business
Table 91. Sun Pharmaceutical Latest Developments
Table 92. Cipla Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Cipla Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 94. Cipla Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 95. Cipla Main Business
Table 96. Cipla Latest Developments
Table 97. Hikma Pharmaceuticals Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Hikma Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 99. Hikma Pharmaceuticals Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 100. Hikma Pharmaceuticals Main Business
Table 101. Hikma Pharmaceuticals Latest Developments
Table 102. Qilu Pharmaceutical Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Qilu Pharmaceutical Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 104. Qilu Pharmaceutical Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 105. Qilu Pharmaceutical Main Business
Table 106. Qilu Pharmaceutical Latest Developments
Table 107. Hansoh Pharmaceuticak Group Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Hansoh Pharmaceuticak Group Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 109. Hansoh Pharmaceuticak Group Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 110. Hansoh Pharmaceuticak Group Main Business
Table 111. Hansoh Pharmaceuticak Group Latest Developments
Table 112. Luye Pharma Group Basic Information, Paliperidone Palmitate Therapeutic Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Luye Pharma Group Paliperidone Palmitate Therapeutic Injection Product Portfolios and Specifications
Table 114. Luye Pharma Group Paliperidone Palmitate Therapeutic Injection Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 115. Luye Pharma Group Main Business
Table 116. Luye Pharma Group Latest Developments


List of Figures
Figure 1. Picture of Paliperidone Palmitate Therapeutic Injection
Figure 2. Paliperidone Palmitate Therapeutic Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paliperidone Palmitate Therapeutic Injection Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Paliperidone Palmitate Therapeutic Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Paliperidone Palmitate Therapeutic Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country/Region (2024)
Figure 10. Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monthly Dosage Form
Figure 12. Product Picture of Quarterly Dosage Form
Figure 13. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type in 2025
Figure 14. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Type (2020-2025)
Figure 15. Paliperidone Palmitate Therapeutic Injection Consumed in General Hospital
Figure 16. Global Paliperidone Palmitate Therapeutic Injection Market: General Hospital (2020-2025) & (K Dose)
Figure 17. Paliperidone Palmitate Therapeutic Injection Consumed in Specialized Hospital
Figure 18. Global Paliperidone Palmitate Therapeutic Injection Market: Specialized Hospital (2020-2025) & (K Dose)
Figure 19. Paliperidone Palmitate Therapeutic Injection Consumed in Others
Figure 20. Global Paliperidone Palmitate Therapeutic Injection Market: Others (2020-2025) & (K Dose)
Figure 21. Global Paliperidone Palmitate Therapeutic Injection Sale Market Share by Application (2024)
Figure 22. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Application in 2025
Figure 23. Paliperidone Palmitate Therapeutic Injection Sales by Company in 2025 (K Dose)
Figure 24. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Company in 2025
Figure 25. Paliperidone Palmitate Therapeutic Injection Revenue by Company in 2025 ($ millions)
Figure 26. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Company in 2025
Figure 27. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Paliperidone Palmitate Therapeutic Injection Sales 2020-2025 (K Dose)
Figure 30. Americas Paliperidone Palmitate Therapeutic Injection Revenue 2020-2025 ($ millions)
Figure 31. APAC Paliperidone Palmitate Therapeutic Injection Sales 2020-2025 (K Dose)
Figure 32. APAC Paliperidone Palmitate Therapeutic Injection Revenue 2020-2025 ($ millions)
Figure 33. Europe Paliperidone Palmitate Therapeutic Injection Sales 2020-2025 (K Dose)
Figure 34. Europe Paliperidone Palmitate Therapeutic Injection Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales 2020-2025 (K Dose)
Figure 36. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Revenue 2020-2025 ($ millions)
Figure 37. Americas Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country in 2025
Figure 38. Americas Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Country (2020-2025)
Figure 39. Americas Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
Figure 40. Americas Paliperidone Palmitate Therapeutic Injection Sales Market Share by Application (2020-2025)
Figure 41. United States Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Paliperidone Palmitate Therapeutic Injection Sales Market Share by Region in 2025
Figure 46. APAC Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Region (2020-2025)
Figure 47. APAC Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
Figure 48. APAC Paliperidone Palmitate Therapeutic Injection Sales Market Share by Application (2020-2025)
Figure 49. China Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. India Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country in 2025
Figure 57. Europe Paliperidone Palmitate Therapeutic Injection Revenue Market Share by Country (2020-2025)
Figure 58. Europe Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
Figure 59. Europe Paliperidone Palmitate Therapeutic Injection Sales Market Share by Application (2020-2025)
Figure 60. Germany Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. France Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Paliperidone Palmitate Therapeutic Injection Sales Market Share by Application (2020-2025)
Figure 68. Egypt Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Paliperidone Palmitate Therapeutic Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Paliperidone Palmitate Therapeutic Injection in 2025
Figure 74. Manufacturing Process Analysis of Paliperidone Palmitate Therapeutic Injection
Figure 75. Industry Chain Structure of Paliperidone Palmitate Therapeutic Injection
Figure 76. Channels of Distribution
Figure 77. Global Paliperidone Palmitate Therapeutic Injection Sales Market Forecast by Region (2026-2031)
Figure 78. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Paliperidone Palmitate Therapeutic Injection Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Paliperidone Palmitate Therapeutic Injection Revenue Market Share Forecast by Application (2026-2031)